EUCTR2013-004946-41-BE进行中（未招募）1 期
The influence of GLP-1 analog, liraglutide, on gastric accommodation, gastric emptying, hunger and the migrating motor complex in healthy volunteers
KULeuven0 个研究点目标入组 0 人开始时间: 2014年10月13日最近更新:
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Healthy volunteers (18-45 years) who have no bowel symptoms and who are in good general health are eligible for the study
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 14
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •-they have relevant underlying disease (cardia, pulmonary, metabolic, kidney or liver diseases...)
- •-They have a history of esophageal or gastric surgery, or recurrent or intermittent upper gastrointestinal symptoms (upper abdominal pain, neusea, vomiting, bothersome fullness or early satiation, heartburn, regurgitation...)
- •-They have a history of allergy to several types of drugs or food
- •-They have been treated for depression
- •-There is a possibly of becoming pregnant during the study period
研究者
相似试验
进行中（未招募）
1 期
Effect of the GLP-1 analogue liraglutide on intragastric pressure and satiation during nutrient drink infusion.healthy volunteersno medical conditiondrugs will be studied because they are known to influence gastric motility.EUCTR2010-023226-20-BEKULeuven
进行中（未招募）
1 期
EFFECTS OF THE GLP-1 RECEPTOR AGONIST LIRAGLUTIDE ON LOWER LIMB PERFUSION IN PEOPLE WITH TYPE 2 DIABETES AND PERIPHERAL ARTERY DISEASE: A RANDOMIZED CONTROLLED TRIAPeripheral Artery Disease and type 2 diabetes mellitusMedDRA version: 20.0Level: LLTClassification code 10053246Term: Type II diabetes peripheral angiopathySystem Organ Class: 100000004866EUCTR2020-002940-22-ITA.O.U. Università degli Studi della Campania Luigi Vanvitelli50
进行中（未招募）
不适用
Assessing the efficacy and safety of the GLP1-agonist liraglutide in patients who developed diabetes as a consequence of the use of anti-psychotic drugsEUCTR2013-005395-18-NLniversity Medical Center Utrecht
撤回
4 期
Effects of GLP1 agonist liraglutide in patients with antipsychotic-drugs-associated diabetes mellitus10018424Diabetes MellitusNL-OMON40321Interne geneeskunde50
进行中（未招募）
1 期
GLIDE: Gastric band and Liraglutide Intervention in Diabetes EvolutioThis trial will investigate the effects of the study treatment arms (gastric band + placebogastric band + liraglutide) on diabetes resolution in obese patients.MedDRA version: 14.1 Level: PT Classification code 10067585 Term: Type 2 diabetes mellitus System Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2011-001538-41-GBniversity of Birmingham200